ParisA brain tumor depends on its own brake.
It offers a way to selectively kill the tumor’s own runaway cells.
Researchers found blocking CReP raises the stress brake, eIF2α phosphorylation, that curbs the tumor’s protein-making overdrive.
The work is preclinical, and no drug reaching CReP has been tested in patients yet.
Sources: Nature